Browse > Article

Diagnosis, Treatment and Prevention of Subcortical Vascular Dementia with a Case Report  

Choi, Seong-Hun (Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University)
Ku, Sae-Kwang (Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University)
Cheon, Woo-Hyun (Department of Neurology, College of Oriental Medicine, Daeggu Haany University)
Baek, Kyung-Min (Department of internal medicine, College of Oriental Medicine, Daeggu Haany University)
Han, Chang-Hyun (TKM Information Research Division, Korea Institute of Oriental Medicine)
Kyung, Jeon-Won (Center for Herbal Medicine Improvement Research, Korea Institute of Oriental Medicine)
Lee, Young-Joon (Department of Preventive Medicine, College of Oriental Medicine, Daeggu Haany University)
Publication Information
Journal of Society of Preventive Korean Medicine / v.14, no.3, 2010 , pp. 63-75 More about this Journal
Abstract
Vascular dementia(VaD) is currently considered to be the second most common type of dementia. VaD is not a single diagnostic entity, but a heterogeneous syndrome which encompasses several clinicopathological forms of dementia resulting from cerebrovascular diseases. A common form of VaD is subcortical VaD which is characterized by lacunar infarcts and deep white matter changes, leading to a progressive decline in memory and cognitive function. The neuropsychological and cognitive profiles of subcortical VaD have been reported relatively homogeneous. At present, subcortical vascular dementia is regarded as the most important subtype of VaD with getting the attention of vascular dementia. The aims of this study are to discuss the concept of subcortical VaD and its importance focusing on diagnosis, prevention and treatment with a case report.
Keywords
Subcortical vascular dementia; Vascular dementia; Case report;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomised double-blind placebocontrolled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 ; 352(9137) : 1347-51.   DOI
2 Kang YW, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination(K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997 ; 15 : 300-307.
3 Kang Y. Samsung Neuropsychological Screening Battery. In : Current research in dementia. Seoul : The Korean Dementia Association, 1998 ; 99-107.
4 Moretti R, Torre P, Antonello RM et al. Rivastigmine in subcortical vascular dementia : An open 22-month study. J Neurol Sci 2002 ; 203-204 : 141-146.   DOI   ScienceOn
5 Santos MD, Alkondon M, Pereira EF et al. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol Pharmacol. 2002 ; 61 : 1222-1234.   DOI   ScienceOn
6 Erkinjuntti T, Kurz A, Gauthier S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : A randomised trial. Lancet 2002 ; 359 : 1283-1290.   DOI   ScienceOn
7 Black S, Roman GC, Geldmacher D et al. Efficacy and tolerability of donepezil in vascular dementia : Positive results of a 24- week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003 ; 34 : 2323-2330.   DOI   ScienceOn
8 Roman GC. Vascular dementia : distinguishing characteristics, treatment and prevention. J Am Geriatr Soc. 2003 ; 51 : 296-304.   DOI   ScienceOn
9 Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000 ; 59 : 23-30.
10 Bowler JV. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 2005 ; 76 (Suppl V) : v35-.v44.   DOI
11 이재홍. 혈관성치매의 치료. 대한신경과학회지. 2003 ; 21 : 445-454.
12 안탁원, 홍석, 김희철. 뇌혈관성치매에 대한 동서의학적 고찰. 한국한의학연구원논문집. 1996 ; 2(1) : 40-70.
13 현경철, 김종우, 황의완. Vascular Dementia에 관한 한의학적 임상연구. 동의신경정신과학회지. 1999 ; 10(1) : 147-157.
14 Chiu HC. Vascular dementia, a new beginning : shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin. 2000 ; 18 : 951-78.   DOI   ScienceOn
15 Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002 ; 1 : 426-36.   DOI   ScienceOn
16 대한치매학회. 치매 임상적 접근. 서울 ; 아카데미아. 2006 : 347-447.
17 de la Torr JC. Vascular risk factor detection and control may prevent Alzheimer's diseas. Ageing Research Review. 2010 ; 9 : 218-225.   DOI   ScienceOn
18 Chiu HC. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001 ; 3(4) : 40-51.   DOI   ScienceOn
19 조맹제 외. 치매 노인 유병률 조사. 보건복지가족부. 2008.
20 Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med. 1996 ; 335(5) : 330-6.   DOI   ScienceOn
21 Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, et al. Vascular dementia : diagnostic criteria for research studies : report of the NINDS-AIREN international workshop. Neurology. 1993 ; 43 : 250-2.   DOI
22 Pratt RD, Perdomo CA. Results of clinical studies with donepezil in vascular dementia. Am J Geriatr Psychiatry 2002 ; 10(Suppl.1) : 88-89.
23 Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300). Stroke. 2002 ; 33 : 1834-1839.   DOI   ScienceOn
24 Rogers SL, Doody RS, Pratt RD Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease : final analysisof a US multicentre openlabel study. Eur. Neuropsychopharmacol. 2000 ; 10 : 195-203.